VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 70 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,093,672 | +15.9% | 141,119 | +71.2% | 0.00% | – |
| Q2 2023 | $943,698 | -29.7% | 82,419 | -52.7% | 0.00% | – |
| Q1 2023 | $1,342,388 | +215.5% | 174,110 | +149.6% | 0.00% | – |
| Q4 2022 | $425,451 | -16.9% | 69,746 | -19.2% | 0.00% | – |
| Q3 2022 | $512,000 | -21.1% | 86,354 | -21.4% | 0.00% | – |
| Q2 2022 | $649,000 | -25.0% | 109,841 | -3.3% | 0.00% | – |
| Q1 2022 | $865,000 | +861.1% | 113,560 | +241.2% | 0.00% | – |
| Q4 2021 | $90,000 | -38.8% | 33,283 | -40.5% | 0.00% | – |
| Q3 2021 | $147,000 | -79.6% | 55,947 | -67.9% | 0.00% | – |
| Q2 2021 | $720,000 | +183.5% | 174,189 | +222.9% | 0.00% | – |
| Q1 2021 | $254,000 | -87.5% | 53,950 | -81.0% | 0.00% | -100.0% |
| Q4 2020 | $2,027,000 | -8.4% | 283,579 | +36.7% | 0.00% | 0.0% |
| Q3 2020 | $2,214,000 | -52.0% | 207,504 | -43.2% | 0.00% | 0.0% |
| Q2 2020 | $4,613,000 | +20.0% | 365,554 | -13.0% | 0.00% | 0.0% |
| Q1 2020 | $3,844,000 | -34.1% | 420,124 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $5,835,000 | -17.6% | 418,290 | +1.6% | 0.00% | -50.0% |
| Q3 2019 | $7,085,000 | -27.2% | 411,688 | +15.1% | 0.00% | -33.3% |
| Q2 2019 | $9,736,000 | +73.7% | 357,664 | +22.1% | 0.00% | +50.0% |
| Q1 2019 | $5,606,000 | +155.3% | 292,918 | +25.4% | 0.00% | +100.0% |
| Q4 2018 | $2,196,000 | -53.4% | 233,644 | -6.1% | 0.00% | 0.0% |
| Q3 2018 | $4,708,000 | +44.7% | 248,838 | +49.4% | 0.00% | 0.0% |
| Q2 2018 | $3,253,000 | +246.8% | 166,514 | +233.5% | 0.00% | – |
| Q1 2018 | $938,000 | +85.7% | 49,930 | +64.2% | 0.00% | – |
| Q4 2017 | $505,000 | -12.9% | 30,408 | +7.9% | 0.00% | – |
| Q3 2017 | $580,000 | +279.1% | 28,172 | +65.3% | 0.00% | – |
| Q2 2017 | $153,000 | -26.1% | 17,048 | +8.9% | 0.00% | – |
| Q1 2017 | $207,000 | -94.7% | 15,649 | -94.9% | 0.00% | -100.0% |
| Q4 2016 | $3,912,000 | -45.2% | 307,095 | -48.3% | 0.00% | -50.0% |
| Q3 2016 | $7,139,000 | -5.8% | 594,422 | -13.8% | 0.00% | 0.0% |
| Q2 2016 | $7,575,000 | +8.8% | 689,245 | -13.6% | 0.00% | 0.0% |
| Q1 2016 | $6,965,000 | -61.0% | 797,817 | -2.2% | 0.00% | -66.7% |
| Q4 2015 | $17,856,000 | – | 815,360 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |